Covid-19 funding stall stymies states’ planning for the next phase

From: POLITICO Pulse - Monday Apr 04,2022 02:03 pm
Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Apr 04, 2022 View in browser
 
POLITICO's Pulse newsletter logo

By Krista Mahr and Sarah Owermohle

Presented by

PhRMA

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

QUICK FIX

States say a crisis is brewing if they don’t get the federal aid they’re expecting to continue vaccination, testing and treatment.

The administration will stop invoking the pandemic to keep migrants out of the country starting next month.

California Gov. Gavin Newsom wants to make insulin, which has become a target in the drug-pricing reform wars.

WELCOME TO MONDAY PULSE A study confirms what many of us have long suspected but willfully ignored: No amount of wine is good for you. Send other disheartening news and tips to kmahr@politico.com and sowermohle@politico.com.

 

A message from PhRMA:

New data show that 35% of insured Americans spent more on out-of-pocket costs than they could afford in the past month. Read more about how insurance is leaving patients exposed to deepening inequities.

 
Driving The Day

STATES STRUGGLE TO PLAN FOR COVID-19 RESPONSE —  A review of more than half a dozen states’ Covid-19 preparedness plans reveals they’re deeply reliant on federal funding for vaccination, testing and treatment for the uninsured, reports POLITICO’s Megan Messerly.

And that’s a problem given that the money from Washington isn’t coming yet.

Health officials from Alabama to Washington state say that congressional gridlock over providing billions in new money has undermined their efforts to transition from crisis response mode to a steady, long-term approach to Covid-19 that can ramp back up in the event of a new wave.

Senators areclosing in on a roughly $10 billion aid package — less than half of the $22.5 billion that the Biden Administration said it needed. That proposal could advance through the upper chamber in the coming days but would still need House approval.

States say they need the additional Covid-specific dollars on top of the funds Congress approved last spring to rebuild their economies, invest in health care infrastructure and support essential workers.

“If Congress doesn’t approve additional funding, then we’re going to have a disaster,” Scott Harris, Alabama’s health officer, told POLITICO. “You would think at some point, somebody could do a cost-benefit analysis here and say paying for people to get tested and to get vaccinated or to get antivirals for Covid is going to be a cost-saving measure compared with ignoring that problem and letting more outbreaks happen.”

ADMINISTRATION TO STOP EXPELLING MIGRANTS IN THE NAME OF COVID-19 — The Centers for Disease Control and Prevention said Friday it will end in May a Trump-era policy that sought to protect Americans’ health by barring migrants from entering the country, Krista reports.

The backstory: The Trump and Biden administrations have used the policy, known as Title 42, to expel nearly 2 million men, women and children since 2020. The CDC recently ended the order permanently for unaccompanied minors. Now, on May 23, it will end for adults and families as well.

The announcement was long overdue, according to public health experts who have argued for years that the CDC order doesn’t make scientific sense as a way to keep Covid-19 out of the U.S. and that public health is being weaponized to control immigration.

The backlash: Several lawmakers — mostly Republicans and a few Democrats — said after the announcement that they don’t think the administration is ready to handle the influx of migrants the decision is expected to bring.

DHS says it is using the time between now and May 23 to ramp up its ability to process arriving men, women and children under standard immigration procedures and last week started an ambitious vaccination program to give thousands of shots each week to people in Customs and Border Protection custody.

THE CalRx QUEST — California continues its push to become the first state drugmaker in a bid to lower drug costs for its residents, POLITICO’s Victoria Colliver writes.

A letter sent Friday from the Department of Finance to legislative budget leaders outlines a plan from Gov. Gavin Newsom to spend $100 million in the 2022–23 budget to produce insulin in the state. Newsom prioritized insulin as a target for the program, under which the state would produce generic drugs under the label CalRx, earlier this year, saying the drug “epitomizes the failures in the pharmaceutical industry.”

Insulin has become a focus of drug-pricing reform as lawmakers have struggled to tackle the problem. The House of Representatives voted last week in favor of a bill to cap out-of-pocket costs for insulin at $35, but the measure faces tough industry opposition and its chances of passing the Senate are slim.

About 3 million Californians are diagnosed with diabetes, and about one-third of them need to take insulin to control the disease.

 

SUBSCRIBE TO NATIONAL SECURITY DAILY : Keep up with the latest critical developments from Ukraine and across Europe in our daily newsletter, National Security Daily. The Russian invasion of Ukraine could disrupt the established world order and result in a refugee crisis, increased cyberattacks, rising energy costs and additional disruption to global supply chains. Go inside the top national security and foreign-policymaking shops for insight on the global threats faced by the U.S. and its allies and what actions world leaders are taking to address them. Subscribe today.

 
 
Coronavirus

BA.2 IN FOCUS —  The highly contagious BA.2 Omicron subvariant accounted for about 54 percent of new cases in the U.S. at the end of March, according to the CDC, but so far, that hasn’t affected the agency’s guidance on the areas of the country at risk, as hospitalizations continue to fall.

POLITICO’s Annette Choi and Taylor Miller Thomas map out the two trends for you here:

BA.2 Subvariant and Hospitalization rate

NYC MAYOR UNDER FIRE FOR COVID-19 POLICIES — Mayor Eric Adams’ handling of the pandemic is under attack from multiple directions.

On Friday, a Staten Island judge struck down New York City’s mask mandate for toddlers, POLITICO’s Amanda Eisenberg reports. Separately, the Police Benevolent Association has launched a lawsuit over the city’s vaccine mandate, citing Adam’s carveout for performers and athletes, POLITICO’s Joe Anuta reports.

In the case of the toddler mask mandate, State Supreme Court Justice Ralph Porzio called the measure “arbitrary, capricious and unreasonable” and said, in a terse ruling, it would be immediately void. Adams had planned to lift the mandate, but cases are on the rise in the city. Adams said his administration would appeal the court’s decision.

As for the vaccine mandate, 1,400 city workers, including 36 members of the NYPD, have been fired for refusing to get a shot. After Adams exempted athletes and performers from the mandate, unions were in an uproar. The police union argues in court papers that the inconsistencies in Adams’ Covid-19 policy are also exemplified by the mayor’s decision to end a vaccine requirement for patrons at restaurants and gyms.

 

A message from PhRMA:

Advertisement Image

 
Around the Agencies

EPA KEEPS TRUMP-ERA RULE ON WATER CONTAMINANT — The EPA upheld a Trump-era decision not to regulate the drinking water contaminant perchlorate, which has polluted drinking water for millions of Americans and is connected to developmental issues in fetuses and children.

POLITICO’s Alex Guillén writes that the agency said the decision not to regulate “is supported by the best available peer reviewed science” and was at least partly due to some states setting their own standards for the contaminant.

The EPA highlighted some actions it planned to take, including funding research to study how firework displays affect groundwater perchlorate levels in the weeks after an event and creating an online “toolkit” with information for drinking-water system managers and communities regarding source-water contamination.

 

STEP INSIDE THE WEST WING: What's really happening in West Wing offices? Find out who's up, who's down, and who really has the president’s ear in our West Wing Playbook newsletter, the insider's guide to the Biden White House and Cabinet. For buzzy nuggets and details that you won't find anywhere else, subscribe today.

 
 
In Congress

GREEN DREAMS — The House passed a marijuana legalization bill Friday largely along party lines and with little hope of landing on President Joe Biden’s desk, POLITICO’s Natalie Fertig writes.

The vote underscored the growing rift between the parties — and even among Democrats — on how to address cannabis policy. Democrats’ inclusion of grants to communities hit hard by the war on drugs alienated some Republicans.

Democrats’ pursuit of their perfect bill worries some pro-cannabis lawmakers and advocates, who don’t see a clear path for sweeping drug policy changes under Republican leadership.

Given that Democrats may not control both houses of Congress come January, the window for federal cannabis policy change may not be closing.

Ukraine

FEAR OF CHEMICAL WEAPONS GROWS — The U.S. has quietly been supplying Ukraine with gas masks, hazmat suits and other protective gear for use if Russia launches a chemical weapons attack, writes POLITICO’s Alexander Ward.

U.S. officials fear Russia is preparing to launch a false-flag operation, leveling baseless claims over chemical and bioweapons attacks at the U.S. as a pretext to use its own.

HHS is providing the equipment; two officials told POLITICO the gear comes from the Strategic National Stockpile. (An NSC spokesperson said the assistance “does not compromise our domestic preparedness.”) The United States Agency for International Development then distributes the PPE, which goes to Ukraine’s Ministry of Health.

Whether it’s ultimately used for civilians or the military is Ukraine’s call.

Meanwhile, Romania is launching a campaign to teach its citizens how to store and take iodine tablets in the event of a nuclear incident, as Russia’s offensive in neighboring Ukraine continues, POLITICO Europe’s Helen Collis reports.

The Russian military has controlled Ukraine’s Zaporizhzhya nuclear power plant since it seized the huge facility on March 4.

What We're Reading

Not all unused vaccines are going to waste. The Texas Tribune reports on an initiative to send vaccines about to expire over the border to Mexico, where people want them.

The New York Times reports that people with diabetes have been hit hard by Covid-19, and researchers are still struggling to understand why.

 

A message from PhRMA:

According to data just released, insurance isn't working for too many patients. Despite paying premiums each month, Americans continue to face insurmountable affordability and access issues:

  • Roughly half (49%) of insured patients who take prescription medicines report facing insurance barriers like prior authorization and “fail first” when trying to access their medicines.
  • More than a third (35%) of insured Americans report spending more in out-of-pocket costs in the last 30 days than they could afford.
Americans need better coverage that puts patients first. Read more in PhRMA’s latest Patient Experience Survey.

 
 

Follow us on Twitter

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

Erin Banco @ErinBanco

Katherine Ellen Foley @katherineefoley

Lauren Gardner @Gardner_LM

Ben Leonard @_BenLeonard_

Rachael Levy @rachael_levy

David Lim @davidalim

Megan Messerly @meganmesserly

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Darius Tahir @dariustahir

Megan R. Wilson @misswilson

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse